Drawing for LIVEREF

USPTO serial 98271407

LIVEREF

Reviewed by CopyMark Law Group

Reg. 7535245Status 700Registered
Filing date
Status date
Registration date
Oct 15, 2024
Examiner
CLARKE, NANCY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LIVEREF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sean D. Detweiler

SEAN D. DETWEILER MORSE, BARNES-BROWN & PENDLETON, P.C.480 TOTTEN POND ROAD, 4TH FLOORCITYPOINTWALTHAM, MA 02451

Goods and services

ClassDescriptionStatusFirst use
042Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory genetic testing, medical diagnostic testing, and pharmacogenetics; Pharmaceutical research services; Pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for conducting pharmaceutical research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing on-line nondownloadable software for conducting pharmaceutical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 15, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 30, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 30, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 21, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 21, 2024DOCKASSIGNED TO EXAMINER—
Dec 20, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 18, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance